Insulin glargine and lixisenatide and Kaletra (Lopinavir and Ritonavir Oral Solution)
Determining the interaction of Insulin glargine and lixisenatide and Kaletra (Lopinavir and Ritonavir Oral Solution) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: lopinavir / ritonavir
Brand name: Kaletra
Synonyms: Kaletra
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Kaletra (Lopinavir and Ritonavir Tablets)
- Insulin glargine and lixisenatide-Kaletra Oral Solution
- Insulin glargine and lixisenatide-Kalexate
- Insulin glargine and lixisenatide-Kalexate Powder
- Insulin glargine and lixisenatide-Kalliga
- Insulin glargine and lixisenatide-Kalosar
- Kaletra (Lopinavir and Ritonavir Oral Solution)-Insulin glargine and lixisenatide Subcutaneous
- Kaletra (Lopinavir and Ritonavir Oral Solution)-Insulin glargine, recombinant Subcutaneous
- Kaletra (Lopinavir and Ritonavir Oral Solution)-Insulin glulisine
- Kaletra (Lopinavir and Ritonavir Oral Solution)-Insulin Glulisine (Cartridges and Pens)
- Kaletra (Lopinavir and Ritonavir Oral Solution)-Insulin Glulisine (Vials)
- Kaletra (Lopinavir and Ritonavir Oral Solution)-Insulin glulisine Subcutaneous